First in Class Inhibitors of ERAP1 Have the Potential to Be a Transformative Immunotherapy in Oncology.
CANCER RESEARCH（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined